Urology · New Hartford, NY
NPI
1568786366
Since 2010
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2 Ellinwood Dr, Apt 19
New Hartford, NY, 13413
Phone (315) 724-1012
Groups this clinician bills Medicare through
Medicare paid, 2024
$463K
23,675 services
Medicare patients, 2024
1,329
Average age 75
Drug cost, 2024
$4.8M
2,469 prescriptions
Company payments, 2025
$80K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Welchons was code J0897 (injection, denosumab, 1 mg), 5,520 times for 29 patients. In total Daniel R Welchons billed 23,675 services in 101 codes, and Medicare paid $463K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,520 | 29 | $20.93 | $116K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,300 | 53 | $0.10 | $538 |
| J9155 Injection, degarelix, 1 mg | Office | 2,560 | 11 | $3.25 | $8,312 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,400 | 24 | $2.26 | $5,418 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,302 | 25 | $44.87 | $58K |
| 81003 Clinical Chemistry | Office | 856 | 527 | $2.18 | $1,865 |
| 36415 Venipuncture Blood Collection | Office | 638 | 463 | $8.53 | $5,444 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 580 | 319 | $11.79 | $6,840 |
| 99214 Office E&M - Established | Office | 573 | 309 | $90.62 | $52K |
| 99213 Office E&M - Established | Office | 281 | 242 | $62.08 | $17K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 279 | 33 | $43.55 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 235 | 34 | $45.62 | $11K |
| 51798 Ultrasound - Nonspecific | Office | 209 | 176 | $7.44 | $1,556 |
| 52000 Cystourethroscopy | Office | 199 | 164 | $165.65 | $33K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 162 | 162 | $49.41 | $8,005 |
By year: 2022 $655K for 18,064 services; 2023 $659K for 26,839 services; 2024 $463K for 23,675 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 856 | 527 | $2.18 | $1,865 |
| 36415 Venipuncture Blood Collection | 638 | 463 | $8.53 | $5,444 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Welchons prescribed most often to Medicare patients was Tamsulosin Hcl, with 475 prescriptions and refills. In total Daniel R Welchons wrote 2,469 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 475 | 1,370 | 156 | $9,022 |
| Orgovyx Relugolix | 429 | 457 | 58 | $1.2M |
| Finasteride Generic | 229 | 667 | 78 | $3,284 |
| Abiraterone Acetate Generic | 145 | 159 | 21 | $503K |
| Prednisone Generic | 136 | 188 | 26 | $655 |
| Cephalexin Generic | 135 | 144 | 107 | $709 |
| Erleada Apalutamide | 118 | 118 | 12 | $1.7M |
| Gemtesa Vibegron | 83 | 143 | 25 | $65K |
| Methenamine Hippurate Generic | 62 | 124 | 19 | $6,843 |
| Xtandi Enzalutamide | 54 | 54 | Under 11 | $734K |
| Potassium Citrate Er Potassium Citrate | 53 | 135 | 18 | $7,953 |
| Alendronate Sodium Generic | 38 | 107 | 14 | $298 |
| Myrbetriq Mirabegron | 38 | 84 | 16 | $36K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 41 | 28 | $192 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 36 | 43 | 28 | $433 |
Brand drugs: - claims; generic drugs: 1,672 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel R Welchons $80K ($80K in general payments such as food, travel and fees) from 25 companies. The largest payer was Teleflex LLC with $73K.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 76 | $73K |
| Bioprotect Medical, Inc. | 7 | $4,598 |
| Janssen Biotech, Inc. JNJ | 5 | $188 |
| Procept Biorobotics Corporation PRCT | 2 | $158 |
| Telix Pharmaceuticals TLX | 5 | $128 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $104 |
| Tolmar, Inc. | 5 | $103 |
| Accord Healthcare, Inc. | 4 | $77.74 |
| Astellas Pharma US Inc 4503.T | 4 | $75.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.